Principal Financial Group Inc Oncocyte Corp Transaction History

Principal Financial Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$2.04 - $3.59 $21,774 - $38,319	-10,674 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$3.53 - $5.89 $439,195 - $732,822	-124,418 Reduced 92.1%	10,674 $38,000
Q2 2021 Aug 10, 2021	BUY	$3.77 - $6.0 $32,817 - $52,230	8,705 Added 6.89%	135,092 $775,000
Q1 2021 May 10, 2021	BUY	$2.39 - $6.5 $266,133 - $723,794	111,353 Added 740.67%	126,387 $656,000
Q4 2020 Feb 08, 2021	BUY	$1.38 - $2.63 $20,746 - $39,539	15,034 New	15,034 $36,000

399K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $238M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Principal Financial Group Inc with notifications on news.